Journal
JOURNAL OF ORAL IMPLANTOLOGY
Volume 46, Issue 6, Pages 562-570Publisher
ALLEN PRESS INC
DOI: 10.1563/aaid-joi-D-19-00208
Keywords
bone substitute; chitosan; melatonin; osteoblast; regeneration
Categories
Funding
- International Team for Implantology Foundation, Switzerland [880_2012]
- Ministry of Science and Technology [MOST 104-2221-E-019-017 -MY3]
- Taiwanese Ministry of National Defense [D101-12-3, MAB-105-091, MAB107-096]
- Tri-Service General Hospital [TSGH-C108-030, TSGHC108-184, TSGH-D-109042, TSGH-D-109169]
- Chi Mei Medical Center [CLFHR10627, CLFHR10726, CMNDMC10909]
- TehTzer Study Group for Human Medical Research Foundation [B1031087, B1051039]
Ask authors/readers for more resources
In terms of a novel scaffold with well good osteoinductive and osteoconductive capacity, melatonin (Mel) possesses positive effects on chemical linkage in scaffold structures, which may allow osteogenic differentiation. The aim of this study is to fabricate Mel-loaded chitosan (CS) microparticles (MPs) as a novel bone substitute through generating a Mel sustained release system from Mel-loaded CS MPs and evaluating its effect on the osteogenic capacity of MC3T3-E1 in vitro. The physical-chemical characteristics of the prepared CS MPs were examined by both Fourier transform infrared spectroscopy and scanning electron microscopy. The released profile and kinetics of Mel from MPs were quantified, and the bioactivity of the released Mel on preosteoblastic MC3T3-E1 cells was characterized in vitro. An in vitro drug release assay has shown high encapsulation efficiency and sustained release of Mel over the investigation period. In an osteogenesis assay, Mel-loaded CS MPs have significantly enhanced alkaline phosphatase (ALP) mRNA expression and ALP activity compared with the control group. Meanwhile, the osteoblast-specific differentiation genes, including runt related transcription factor 2 (Runx2), bone morphogentic protein-2 (Bmp2), collagen I (Col I), and osteocalcin (Ocn), were also significantly upregulated. Furthermore, quantificational alizarin red-based assay demonstrated that Mel-loaded CS MPs notably enhanced the calcium deposit of MC3T3-E1 compared with controls. In essence, Mel-loaded CS MPs can control the release of Mel for a period of time to accelerate osteogenic differentiation of preosteoblast cells in vitro.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available